Table 3.
Control | OSA | |||||
---|---|---|---|---|---|---|
Total CEC | ABCA1 CEC | Non ABCA1 CEC | Total CEC | ABCA1 CEC | Non ABCA1 CEC | |
Age | 0.035 | −0.260 | 0.226 | −0.071 | − 0.137 | 0.005 |
BMI | −0.060 | − 0.003 | − 0.075 | −0.126 | − 0.164 | −0.049 |
SBP | 0.002 | 0.024 | −0.014 | −0.097 | − 0.193 | 0.012 |
DBP | −0.088 | −0.075 | − 0.061 | −0.033 | − 0.058 | −0.002 |
AHI | −0.079 | 0.273 | −0.292 | −0.347** | − 0.353** | −0.208 |
AHIREM | −0.082 | 0.188 | −0.255 | −0.286* | − 0.316* | −0.204 |
AHINREM | −0.103 | 0.275 | −0.277 | −0.389** | − 0.397** | −0.251 |
AverageSpO2 | 0.235 | 0.167 | 0.186 | 0.108 | 0.206 | −0.006 |
FBS | −0.023 | 0.027 | −0.048 | −0.018 | − 0.222 | 0.140 |
Insulin | −0.108 | −0.124 | − 0.053 | −0.160 | − 0.173 | −0.089 |
HOMA-IR | −0.091 | −0.102 | − 0.045 | −0.173 | − 0.221 | −0.070 |
TC | 0.178 | 0.131 | 0.137 | −0.113 | −0.205 | − 0.002 |
TG | 0.028 | 0.139 | −0.061 | −0.333** | − 0.296* | −0.231 |
HDL-C | 0.400 | 0.097 | 0.447* | 0.378** | 0.129 | 0.415** |
LDL-C | 0.133 | −0.235 | 0.334 | −0.160 | − 0.305* | 0.009 |
AIP | −0.281 | −0.291 | − 0.097 | −0.476** | − 0.411** | −0.314** |
Apo A-I | 0.397 | 0.359 | 0.260 | 0.419** | 0.417** | 0.258* |
Apo B | 0.094 | −0.121 | 0.205 | −0.112 | − 0.121 | −0.062 |
ApoB/ApoA-I | −0.180 | −0.390 | 0.041 | −0.350** | − 0.342** | −0.219 |
hsCRP | −0.008 | 0.093 | −0.183 | −0.359** | − 0.422** | −0.173 |
Arylesterase | 0.190 | −0.047 | 0.277 | 0.136 | −0.012 | 0.192 |
Paraoxonase | 0.141 | 0.011 | 0.174 | 0.155 | 0.106 | 0.131 |
BMI Body mass index, SBP Systolic blood pressure, DBP Diastolic blood pressure, AHI Apnea hypopnea index, REM Rapid eye movement, NREM Non-rapid eye movement, FBG Fasting blood glucose, HOMA-IR Homeostatic model assessment for insulin resistance, TC Total cholesterol, TG Triglyceride, HDL-C High density lipoprotein-cholesterol, LDL-C Low density lipoprotein-cholesterol, AIP Atherogenic index of plasma, apo A-I Apolipoprotein A-I, apo B Apolipoprotein B, hsCRP High sensitivity C-reactive protein